Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Three Amigos Stock Thread -- Ignore unavailable to you. Want to Upgrade?

To: Sergio H who wrote (14849)	4/4/1999 8:28:00 PM
From: scouser	Read Replies (1) \| Respond to of 29382

CYTR, I got this from a T/A thread , the T/A looks great, maybe ready for another bounce, the MACD will cross above 0 ,and the histogram is about to + ,mon or tue possibly. clearstation.com "CytRx is a biopharmaceutical company focused on the development and commercialization of high-value human therapeutics. The Company's lead product is FLOCOR(TM), now in pivotal Phase III clinical trials, for the treatment of acute sickle cell crisis. CytRx is also developing FLOCOR(TM) for acute respiratory disorders and plans to expand into other vascular disorders such as shock and stroke over time. CytRx currently has a research pipeline with opportunities in the areas of infectious disease, gene and drug delivery, vaccines, and animal feed additives." scouser